BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5389567)

  • 1. [Alpha l-acid glycoprotein. 1. Isolation and purification of alpha l-acid glycoprotein in the ascitic fluid of human stomach cancer].
    Horikawa M; Kurokawa M; Hotta K
    Seikagaku; 1969 Oct; 41(10):717-21. PubMed ID: 5389567
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification and characterization of alpha 1-acid glycoprotein from ascitic fluid.
    Hotta K; Horikawa M; Kurokawa M
    Anal Biochem; 1970 Feb; 33(2):463-8. PubMed ID: 4985784
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties of 1 -acid glycoprotein from ascitic fluids.
    Horikawa M; Kurokawa M; Hotta K
    Kitasato Arch Exp Med; 1970 Jun; 43(1):1-9. PubMed ID: 4998553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alpha 1-acid glycoprotein. II. Properties of alpha 1-acid glycoprotein of ascitic and pleural fluids].
    Hamazaki M; Kurokawa M; Hotta K
    Seikagaku; 1972 Jun; 44(6):255-60. PubMed ID: 4672828
    [No Abstract]   [Full Text] [Related]  

  • 5. Purification and characterization of immunosuppressive (IS) substance obtained from ascitic fluids of patients with gastrointestinal cancer.
    Fujii M; Takahashi N; Hayashi H; Matsunaga K; Yoshikumi C
    Clin Biochem; 1987 Jun; 20(3):183-9. PubMed ID: 3652440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on liver cancer. I. Immunofluorescent studies on the localization of -fetoprotein in patients with primary liver cancer.
    Koda T; Ishigami S; Tanabe S
    Biken J; 1971 Dec; 14(4):369-77. PubMed ID: 4113499
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycoproteins in effusions of gelatinous diseases of the peritoneum].
    Ekindjian OG; Jardillier JC; Agneray J
    Ann Biol Clin (Paris); 1972; 30(1):29-36. PubMed ID: 5021961
    [No Abstract]   [Full Text] [Related]  

  • 8. [Isolation and analysis of an acidic sulfated glycoprotein from a tumoral secretion of ovarian origin].
    Ekindjian OG; Jardillier JC; Roux M; Agneray J
    Biomedicine; 1974 Sep; 20(5):358-65. PubMed ID: 4451698
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial purification and characterization of a lymphocyte-inhibitory factor(s) in ascitic fluids from ovarian cancer patients.
    Hess AD; Gall SA; Dawson JR
    Cancer Res; 1980 Jun; 40(6):1842-51. PubMed ID: 6966184
    [No Abstract]   [Full Text] [Related]  

  • 10. [Structure of carbohydrate chains of molecular forms of alpha1-acidic glycoprotein from ascitic fluid from patients with stomach cancer].
    Shiian SD; Nasonov VV; Bovin NV; Aleshkin VA; Novikova LI; Liutov AG
    Bioorg Khim; 1994 Oct; 20(10):1125-31. PubMed ID: 7826409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of alpha 1-acid glycoprotein molecular variants in ascitic fluid of cancer and non-cancer patients.
    Fujii M; Takahashi N; Hayashi H; Furusho T; Matsunaga K; Yoshikumi C
    Anticancer Res; 1988; 8(3):303-6. PubMed ID: 3389735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a human, endogenous, phospholipase A2 inhibitory, antiinflammatory protein.
    Longenecker JP; Rose JW; Giffin K; Shepard D; Johnson LK
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():581-6. PubMed ID: 2959117
    [No Abstract]   [Full Text] [Related]  

  • 13. Purification and partial characterization of a Mr 52,000 glycoprotein from human cancer ascites fluid which stimulates bone resorption in vitro.
    Lamkin MS; Colclasure C; Lloyd WS; Doherty JM; Gonnerman W; Schmid K; Nimberg RB
    Cancer Res; 1986 Sep; 46(9):4650-5. PubMed ID: 3731118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of fibrinogen in the ascitic and pleural fluids and its clinicopathological significance].
    Takayanagi N; Iwaki M
    Rinsho Byori; 1971 Nov; 19(11):797-801. PubMed ID: 5168418
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification of fibrinogen or fibrin degradation products in the ascitic fluid].
    Kolodie L; Detante J; Rachail M
    Nouv Presse Med; 1978 Feb; 7(8):665. PubMed ID: 417295
    [No Abstract]   [Full Text] [Related]  

  • 16. A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.
    Pedersen N; Schmitt M; Rønne E; Nicoletti MI; Høyer-Hansen G; Conese M; Giavazzi R; Dano K; Kuhn W; Jänicke F
    J Clin Invest; 1993 Nov; 92(5):2160-7. PubMed ID: 8227331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural characterization of the C-reactive protein].
    Pérez Miranda M; Liso Irurzun P
    Rev Med Univ Navarra; 1972 Sep; 16(3):217-25. PubMed ID: 4210388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Case of Krukenberg's tumor originating in the stomach with a marked increase in the ascitic carcinoembryonic antigen (CEA) level in comparison with that of the blood].
    Kohno H; Morimoto S; Onishi T; Tahara Y; Kumahara Y
    Nihon Naika Gakkai Zasshi; 1983 Apr; 72(4):462-7. PubMed ID: 6310009
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of chloroform on ascitic fluid proteins in vaccinated rats].
    Bocharova NG; Golshmid VK; Gavrilenkova VIu
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov; 47(11):95-8. PubMed ID: 5505314
    [No Abstract]   [Full Text] [Related]  

  • 20. The purification procedure for human gastric juice FSA and its chemical composition.
    Häkkinen IP
    Clin Exp Immunol; 1980 Oct; 42(1):57-62. PubMed ID: 7460391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.